Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 8

Results: 28

Correction to: Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.

Published in:

2021

By:

Sasidharan Nair, Varun;
Saleh, Reem;
Toor, Salman M.;
Cyprian, Farhan S.;
Elkord, Eyad

Publication type:

Correction Notice

Correction to: Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti‑B7H3 immunotherapy.

Published in:

2021

By:

Kramer, Kim;
Donzelli, Maria A.;
Pessin, Melissa S.

Publication type:

Correction Notice

Correction to: The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta‑analysis.

Published in:

2021

By:

You, Yafei;
Jiang, Chang;
Peng, Kunwei;
He, Wenzhuo;
Wang, Lei;
Jin, Yanan;
Xia, Liangping

Publication type:

Correction Notice

Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2367, doi. 10.1007/s00262-021-02868-w

By:

Li, Yuan;
Chen, Zuhua;
Tao, Weiping;
Sun, Nan;
He, Jie

Publication type:

Article

Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2339, doi. 10.1007/s00262-021-02867-x

By:

Tsai, Yi-Fang;
Huang, Chi-Cheng;
Lin, Yen-Shu;
Hsu, Chih-Yi;
Huang, Ching-Po;
Liu, Chun-Yu;
Chiu, Jen-Hwey;
Tseng, Ling-Ming

Publication type:

Article

A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2301, doi. 10.1007/s00262-021-02864-0

By:

Nagata, Marino;
Kosaka, Akemi;
Yajima, Yuki;
Yasuda, Syunsuke;
Ohara, Mizuho;
Ohara, Kenzo;
Harabuchi, Shohei;
Hayashi, Ryusuke;
Funakoshi, Hiroshi;
Ueda, Jun;
Kumai, Takumi;
Nagato, Toshihiro;
Oikawa, Kensuke;
Harabuchi, Yasuaki;
Esteban, Celis;
Ohkuri, Takayuki;
Kobayashi, Hiroya

Publication type:

Article

miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2247, doi. 10.1007/s00262-021-02862-2

By:

Meng, Fanyi;
Yang, Man;
Chen, Yinshuang;
Chen, Weichang;
Wang, Weipeng

Publication type:

Article

Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2401, doi. 10.1007/s00262-021-02861-3

By:

O'Brien, Sarah A.;
Orf, Jessica;
Skrzypczynska, Katarzyna M.;
Tan, Hong;
Kim, Jennie;
DeVoss, Jason;
Belmontes, Brian;
Egen, Jackson G.

Publication type:

Article

CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2353, doi. 10.1007/s00262-021-02859-x

By:

Lam, Jian Hang;
Hong, Michelle;
Koo, Si-Lin;
Chua, Clarinda Wei Ling;
Lim, Kah Ling;
Wee, Felicia;
Wan, Wei Keat;
Leow, Wei Qiang;
Yeo, Joo Guan;
Tan, Iain Bee Huat;
Yeong, Joe;
Lim, Tony Kiat Hon;
Lim, Tong Seng

Publication type:

Article

The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2323, doi. 10.1007/s00262-021-02858-y

By:

You, Yafei;
Jiang, Chang;
Peng, Kunwei;
He, Wenzhuo;
Wang, Lei;
Jin, Yanan;
Xia, Liangping

Publication type:

Article

Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2125, doi. 10.1007/s00262-021-02857-z

By:

Zanker, Damien J.;
Owen, Katie L.;
Baschuk, Nikola;
Spurling, Alex J.;
Parker, Belinda S.

Publication type:

Article

Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2209, doi. 10.1007/s00262-021-02855-1

By:

Tyan, Kevin;
Baginska, Joanna;
Brainard, Martha;
Giobbie-Hurder, Anita;
Severgnini, Mariano;
Manos, Michael;
Haq, Rizwan;
Buchbinder, Elizabeth I.;
Ott, Patrick A.;
Hodi, F. Stephen;
Rahma, Osama E.

Publication type:

Article

Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2103, doi. 10.1007/s00262-020-02842-y

By:

Sasidharan Nair, Varun;
Saleh, Reem;
Toor, Salman M.;
Cyprian, Farhan S.;
Elkord, Eyad

Publication type:

Article

CAR19/22 T cell therapy in adult refractory Burkitt's lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2379, doi. 10.1007/s00262-021-02850-6

By:

Zhou, Xiaoxi;
Ge, Tong;
Li, Tongjuan;
Huang, Liang;
Cao, Yang;
Xiao, Yi;
Zhen, Miao;
Chen, Liting;
Zhou, Jianfeng

Publication type:

Article

Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2261, doi. 10.1007/s00262-021-02848-0

By:

Zhong, Runbo;
Zhang, Yunbin;
Chen, Dongfang;
Cao, Shuhui;
Han, Baohui;
Zhong, Hua

Publication type:

Article

The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2313, doi. 10.1007/s00262-021-02847-1

By:

Jiang, Long;
Huang, Jia;
Jiang, Shanshan;
Rong, Wenwen;
Shen, Yaofeng;
Li, Chongwu;
Tian, Yu;
Ning, Junwei;
Chen, Xiaoke;
Yang, Yunhai;
Ding, Zhengping;
Li, Ziming;
Luo, Qingquan

Publication type:

Article

Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2151, doi. 10.1007/s00262-020-02844-w

By:

Melssen, Marit M.;
Pollack, Karlyn E.;
Meneveau, Max O.;
Smolkin, Mark E.;
Pinczewski, Joel;
Koeppel, Alexander F.;
Turner, Stephen D.;
Sol-Church, Katia;
Hickman, Alexandra;
Deacon, Donna H.;
Petroni, Gina R.;
Slingluff, Craig L.

Publication type:

Article

Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2197, doi. 10.1007/s00262-021-02851-5

By:

Hoa, Sabrina;
Laaouad, Linda;
Roberts, Janet;
Ennis, Daniel;
Ye, Carrie;
Al Jumaily, Karam;
Pope, Janet;
Nevskaya, Tatiana;
Saltman, Alexandra;
Himmel, Megan;
Rottapel, Robert;
Ly, Christina;
Colmegna, Ines;
Fifi-Mah, Aurore;
Maltez, Nancy;
Tisseverasinghe, Annaliese;
Hudson, Marie;
Jamal, Shahin

Publication type:

Article

Therapeutic vaccination targeting CD40 and TLR3 controls melanoma growth through existing intratumoral CD8 T cells without new T cell infiltration.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2139, doi. 10.1007/s00262-020-02841-z

By:

Stevens, Aaron D.;
Bullock, Timothy N. J.

Publication type:

Article

T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2291, doi. 10.1007/s00262-020-02839-7

By:

Stahlie, Emma H. A.;
Franke, Viola;
Zuur, Charlotte L.;
Klop, Willem M. C.;
van der Hiel, Bernies;
Van de Wiel, Bart A.;
Wouters, Michel W. J. M.;
Schrage, Yvonne M.;
van Houdt, Winan J.;
van Akkooi, Alexander C. J.

Publication type:

Article

Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2389, doi. 10.1007/s00262-020-02837-9

By:

Salehi-Rad, Ramin;
Li, Rui;
Tran, Linh M.;
Lim, Raymond J.;
Abascal, Jensen;
Momcilovic, Milica;
Park, Stacy J.;
Ong, Stephanie L.;
Shabihkhani, Maryam;
Huang, Zi Ling;
Paul, Manash;
Shackelford, David B.;
Krysan, Kostyantyn;
Liu, Bin;
Dubinett, Steven M.

Publication type:

Article

Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2275, doi. 10.1007/s00262-020-02835-x

By:

Traxel, Sabrina;
Lehmann, Julia;
Richard, Stefanie;
Sidorov, Semjon;
Niggli, Felix;
Berger, Christoph;
Nadal, David;
Bürgler, Simone

Publication type:

Article

Immunotherapy response modeling by ex-vivo organ culture for lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2223, doi. 10.1007/s00262-020-02828-w

By:

Kamer, Iris;
Bab-Dinitz, Elizabeta;
Zadok, Oranit;
Ofek, Efrat;
Gottfried, Teodor;
Daniel-Meshulam, Inbal;
Hout-Siloni, Goni;
Ben Nun, Alon;
Barshack, Iris;
Onn, Amir;
Bar, Jair

Publication type:

Article

Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2411, doi. 10.1007/s00262-020-02824-0

By:

Kramer, Kim;
Donzelli, Maria A.;
Pessin, Melissa S.

Publication type:

Article

Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2165, doi. 10.1007/s00262-020-02816-0

By:

Liu, Qiaofei;
Zhang, Ronghua;
Zhang, Xiang;
Liu, Jingkai;
Wu, Huanwen;
Li, Yuan;
Cui, Ming;
Li, Tong;
Song, Huixin;
Gao, Junyi;
Zhang, Yalu;
Yang, Sen;
Liao, Quan

Publication type:

Article

Pembrolizumab-induced immune-mediated fatal colitis with concurrent giardia infection.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2385, doi. 10.1007/s00262-020-02815-1

By:

Sisman, Gurhan;
Barbur, Erol;
Saka, Didem;
Erdamar Cetin, Sibel

Publication type:

Article

Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2179, doi. 10.1007/s00262-020-02792-5

By:

O'Melia, Meghan J.;
Manspeaker, Margaret P.;
Thomas, Susan N.

Publication type:

Article

LncRNA UCA1 attenuated the killing effect of cytotoxic CD8 + T cells on anaplastic thyroid carcinoma via miR-148a/PD-L1 pathway.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2235, doi. 10.1007/s00262-020-02753-y

By:

Wang, Xiaoming;
Zhang, Yan;
Zheng, Jian;
Yao, Cuixian;
Lu, Xiubo

Publication type:

Article